Chen, Bi-Xing <br/><br/>
Cell cycle inhibition by an anti-cyclin D1 antibodychemically modified for intracellular delivery.  [electronic resource] 

 -  Cancer letters  Nov 2006 
 - 71-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0304-3835 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2005.12.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--chemistry<br/>Cell Cycle--drug effects<br/>Cell Proliferation<br/>Cyclin D1--immunology<br/>Drug Delivery Systems<br/>HT29 Cells--drug effects<br/>Humans<br/>Immunoenzyme Techniques<br/>Mice<br/>NIH 3T3 Cells--drug effects<br/>Neoplasms--pathology<br/>Peptides--chemistry<br/>Tumor Cells, Cultured